glp-1 news today november 2025 Mapping the effectiveness and risks of receptor agonists Poll: 1 in 8 Adults

Percentage of Mounjaro Users Experiencing Vision Changes The use of a GLP-1 drug is associated with a fourfold higher risk of NAION when used to treat type 2 diabetes

We know it is harder for individuals with diabetes to lose weight

GCSI Scoring System for Patient-Reported Outcomes The GCSI is a patient-based symptom instrument in which the score is a sum of three subscale scores (each ranging from 1 to 3) for the three main symptom complexes: 1

Report these symptoms to your doctor immediately, as acute cholecystitis requires emergency evaluation

There is no approved label, no pharmacy product, and the Phase 3 TRIUMPH program is still enrolling and reporting

The risk of bias in the included cohort studies was assessed using Newcastle-Ottawa Quality Assessment Form for Cohort Studies (NOS)